EPO decision T 2963/19: A reasonable expectation of success
The European Patent Office (EPO) has a growing body of case law relating to the significance of clinical trial protocols when assessing novelty and inventive step The latest in this line of… read more…
Number of UK trade mark disputes more than doubles to record high as Brexit triggers intellectual property battles
Data provided by Mathys & Squire has featured in an article by The Times, Tech Register, World Intellectual Property Review, Institute of Export and International Trade and City… read more…
European Patent Office proposes to abolish the ’10-day rule’
UPDATE as of 19 October 2023 The European Patent Office (EPO)’s ‘10-day rule’ will cease to exist from 1 November 2023 From that date, EPO communications will be deemed to be delivered on… read more…
UK fashion trade marks owned by online fast fashion houses jump 163% in last five years
Data provided by Mathys & Squire has featured in an article by The Trademark Lawyer, highlighting a surge in trade marks owned by online fast fashion retailers The number of trade… read more…
Managing IP ranks Mathys & Squire attorneys as IP STARS in 2022 edition
The 2022 edition of Managing IP’s IP STARS directory has now been released and Mathys & Squire is delighted to have six practitioners named ‘IP Stars’ We are pleased to… read more…
Eight of top 10 UK litigation funders now actively seeking intellectual property cases as startups look to take on industry giants
Data provided by Mathys & Squire has featured in an article by City AM highlighting UK litigation funders’ increased interest in intellectual property cases Click here to read the… read more…
Industries that have experienced challenges during the COVID-19 crisis and the role that IP has played – Case study: Logistics
(C) Naomi Korn Associates & Mathys & Squire 2022 Some Rights Reserved These case studies are licensed for reuse under the terms of a Creative Commons Attribution Share Alike… read more…
Mathys & Squire appoints biotech Partner Iain Armstrong
We are pleased to announce the appointment of a biotech Partner Iain Armstrong Iain has over 20 years’ experience advising clients in the life sciences field, providing practical and pragmatic… read more…
T 1024/18 and description amendments: a sequel to T 1989/18
Update: 12 May 2022 T 1444/20 of 28 April 2022 cites and agrees with T 1989/19, finding that “claim-like clauses” in the description, labelled as “specific embodiments of the… read more…
